stockportfolio.pro
Astrana Health, Inc. P/E Ratio 2011–2025
Astrana Health, Inc. (ASTH) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +8.0%/yr over 14 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 53.93 | +54.0% |
| FY 2024 | 35.03 | +18.0% |
| FY 2023 | 29.69 | -0.7% |
| FY 2022 | 29.89 | -38.2% |
| FY 2021 | 48.34 | +167.2% |
| FY 2020 | 18.09 | -61.7% |
| FY 2019 | 47.21 | -31.0% |
| FY 2018 | 68.45 | +156.7% |
| FY 2017 | 26.67 | — |
| FY 2017 | — | — |
| FY 2016 | 18.29 | — |
| FY 2016 | — | — |
| FY 2015 | — | — |
| FY 2014 | — | — |
| FY 2013 | — | — |
| FY 2012 | — | — |
| FY 2011 | — | — |
Source: Astrana Health, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Astrana Health, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAstrana Health, Inc. — frequently asked questions
What is Astrana Health, Inc.'s price-to-earnings ratio?
Astrana Health, Inc. (ASTH) reported price-to-earnings ratio of 53.93 for fiscal year 2025, per its SEC filings.
How has Astrana Health, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2011 and 2025, ASTH's price-to-earnings ratio grew at roughly 8.0% per year (compound annual rate), from 18.29 to 53.93.
Where does this data come from?
Figures are computed from Astrana Health, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.